GPT Healthcare Limited reported an 18% year-on-year increase in total income to Rs. 128.2 crore for the first quarter ended June 30, 2026, driven by higher patient volumes, improved occupancy across mature hospitals, and continued expansion of high-value specialty services.

The hospital chain posted EBITDA of Rs. 26.2 crore, up 38.5% from Rs. 18.9 crore in the corresponding quarter last year, with EBITDA margin improving to 20.4% from 17.4%. Profit after tax (PAT) rose 65.7% year-on-year to Rs. 12.7 crore, while PAT margin expanded to 9.9% from 7.1%.

During the quarter, GPT Healthcare maintained an average revenue per occupied bed (ARPOB) of Rs. 42,350 while occupancy at its mature hospitals improved to 58.07%. Including the newly operational Raipur facility, overall occupancy stood at 45.5%.

Operationally, the company strengthened its advanced care portfolio across its network. ILS Dum Dum completed over 700 renal transplants, ILS Howrah launched its MAKO robotic knee surgery programme, ILS Agartala performed more than 700 radiation therapy procedures, and ILS Salt Lake crossed the milestone of 800 robotic surgeries.

The Raipur hospital received its liver transplant licence and is expected to achieve operational break-even by Q3 FY27. Meanwhile, construction of the company's Jamshedpur hospital remains on schedule for completion by Q4 FY27. GPT Healthcare also expanded its clinical research capabilities through participation in the BEMAKI acute kidney injury trial.

Dr. Om Tantia, Chairman, GPT Healthcare, said: “In line with its capital-efficient expansion strategy, the Company is in the process of finalizing its seventh hospital, which is expected to increase the network’s total capacity to more than 1,000 beds.”

“Supported by standardized clinical governance and ongoing improvements in care quality, patient outcomes, and operational efficiency, these initiatives are expected to unlock operating leverage and deliver sustainable returns while preserving the Company’s net-debt-free position,” he added.